Literature DB >> 21171525

The energetic and metabolic effect of Ringerfundin (B. Braun) infusion and comparison with Plasma-Lyte (Baxter) in healthy volunteers.

Zdenek Zadák1, Radomír Hyspler, Miloslav Hronek, Alena Tichá.   

Abstract

Measurement of parameters of energy requirement, respiratory quotient (RQ), rate of oxygen consumption (VO2) and rate of carbon dioxide production (VCO2) reveal Ringerfundin as an excellent and metabolically stable-acting balanced ionic solution, which does not increase the consumption of O2 or the total energy requirement. In conclusion, Ringerfundin was very well tolerated and in no case were observed undesirable effects.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21171525     DOI： 10.14712/18059694.2016.72

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN： 1211-4286


  4 in total

Review 1.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

Review 2.  Comparison of Balanced Crystalloid Solutions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jeffrey D Curran; Paityn Major; Kent Tang; Sean M Bagshaw; Joanna C Dionne; Kusum Menon; Bram Rochwerg
Journal:  Crit Care Explor       Date:  2021-05-14

3.  Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation : Prospective, randomized, controlled trial.

Authors:  Carmen Pfortmueller; Georg-Christian Funk; Eva Potura; Christian Reiterer; Florian Luf; Barbara Kabon; Wilfred Druml; Edith Fleischmann; Gregor Lindner
Journal:  Wien Klin Wochenschr       Date:  2017-03-02       Impact factor: 1.704

Review 4.  Clinical physiology aspects of chloremia in fluid therapy: a systematic review.

Authors:  David Astapenko; Pavel Navratil; Jiri Pouska; Vladimir Cerny
Journal:  Perioper Med (Lond)       Date:  2020-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.